This workshop will review the state of the science supporting clinical applications of probiotics in promoting and sustaining health and in the management of disease conditions. It will also explore how the current regulatory status of probiotics, which are marketed mostly as foods and dietary supplements in the United States, impacts the clinical evaluation of probiotics. Limitations and gaps in the current body of evidence, as well as scientific and regulatory hurdles, will be identified and recommendations will be provided regarding areas in need of future support. NIH is one of the cosponsors of the workshop.
Developing Probiotics as Foods and Drugs
September 29th, 2006 · No Comments
Tags: Alternative Medicine